Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.20.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Revenues:    
Collaboration revenue $ 2,014 $ 6,564
Operating expenses:    
Research and development 6,307 4,004
General and administrative 5,293 4,863
Impairments 46,103
Total operating expenses 11,600 54,970
Loss from operations (9,586) (48,406)
Other (expense) income:    
Interest expense, net (8) (19)
Change in fair value of derivative liabilities (54) 256
Total other income (expense), net (62) 237
Loss before income taxes (9,648) (48,169)
Income tax
Net loss $ (9,648) $ (48,169)
Net loss per common share:    
Loss per share, basic and diluted $ (0.17) $ (1.51)
Weighted average number of common shares outstanding, basic and diluted 55,217 31,859